GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zealand Pharma A/S (OCSE:ZEAL) » Definitions » Other Stockholders Equity

Zealand Pharma A/S (OCSE:ZEAL) Other Stockholders Equity : kr22.7 Mil (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Zealand Pharma A/S Other Stockholders Equity?

Zealand Pharma A/S's Other Stockholders Equity for the quarter that ended in Mar. 2024 was kr22.7 Mil.

Zealand Pharma A/S's quarterly Other Stockholders Equity increased from Sep. 2023 (kr11.3 Mil) to Dec. 2023 (kr22.7 Mil) and increased from Dec. 2023 (kr22.7 Mil) to Mar. 2024 (kr22.7 Mil).

Zealand Pharma A/S's annual Other Stockholders Equity increased from Dec. 2021 (kr0.0 Mil) to Dec. 2022 (kr14.6 Mil) and increased from Dec. 2022 (kr14.6 Mil) to Dec. 2023 (kr22.7 Mil).

Zealand Pharma A/S Other Stockholders Equity Historical Data

The historical data trend for Zealand Pharma A/S's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zealand Pharma A/S Other Stockholders Equity Chart

Zealand Pharma A/S Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 14.62 22.70

Zealand Pharma A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.40 18.38 11.29 22.70 22.72

Zealand Pharma A/S Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Zealand Pharma A/S Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Zealand Pharma A/S's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Zealand Pharma A/S (OCSE:ZEAL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zealand Pharma A/S (OCSE:ZEAL) » Definitions » Other Stockholders Equity
Comparable Companies
OCSE:ALK B OCSE:BAVA OCSE:GUBRA OCSE:PEG A OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX BGNE SZSE:300122 ALNY OCSE:GMAB XKRX:068270 BMRN
Traded in Other Exchanges
ZLDPF:USA ZEALc:UK 0NZU:UK 22Z:Germany
Address
Sydmarken 11, Soborg, DNK, DK-2860
Website
https://www.zealandpharma.com
Zealand Pharma A/S is a biotechnology company. It is focused on the discovery, design, and development of peptide-based medicines. The company's product pipeline includes three product candidates in clinical development: glepaglutide, which is being developed to treat short bowel syndrome or SBS; dasiglucagon formulated for use in a dual-hormone artificial pancreas system for diabetes management; and dasiglucagon for use in the treatment of congenital hyperinsulinism. The company has out-licensed a peptide program to Boehringer Ingelheim that has been moved ahead into early clinical development: a once-weekly novel dual-acting GLP-1/glucagon agonist for the treatment of obesity and/or Type 2 diabetes.